Neogen reported $604.6M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agilent USD 4.76B 148M Mar/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Danaher USD 13.38B 554M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Illumina USD 2.83B 96M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Neogen USD 604.6M 14.6M Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Pacific Biosciences Of California USD 369.52M 5.54M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
Rockwell Medical USD 31.61M 1.42M Jun/2025
STAAR Surgical USD 312.4M 853K Mar/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Utah Medical Products USD 100.38M 2.64M Mar/2026
Zoetis USD 6.47B 294M Mar/2026